Skip to main content

Advertisement

Table 1 Characteristics of the 240 patients with locoregionally advanced nasopharyngeal carcinoma (NPC)

From: Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study

Characteristic NAC + IMRT [cases (%)] CCRT + AC [cases (%)] χ2 P
Total 117 123   
Age (years)    0.199 0.656
 <50 83 (70.9) 84 (68.3)   
 ≥50 34 (29.1) 39 (31.7)   
Gender    1.148 0.284
 Male 89 (76.1) 86 (69.9)   
 Female 28 (23.9) 37 (30.1)   
T stage    1.029 0.794
 T1 4 (3.4) 4 (3.3)   
 T2 11 (9.4) 14 (11.4)   
 T3 57 (48.7) 65 (52.8)   
 T4 45 (38.5) 40 (32.5)   
N stage    3.578 0.311
 N0 22 (18.8) 27 (22.0)   
 N1 40 (34.2) 50 (40.6)   
 N2 46 (39.3) 42 (34.1)   
 N3 9 (7.7) 4 (3.3)   
Clinical stage    2.256 0.133
 III 65 (55.6) 80 (65.0)   
 IV 52 (44.4) 43 (35.0)   
WHO histology    0.313 0.576
 II 13 (11.1) 11 (8.9)   
 III 104 (88.9) 112 (91.1)   
  1. NAC neoadjuvant chemotherapy, IMRT intensity-modulated radiotherapy, CCRT concurrent chemoradiotherapy, AC adjuvant chemotherapy, WHO World Health Organization